Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

INTRODUCTION. Tumor growth rate (TGR; percent size change per month [%/m]) is postulated to be an early radiological biomarker to overcome limitations of RECIST. This study aimed to assess the impact of TGR in neuroendocrine tumors (NETs) and potential clinical and therapeutic applications. MATERIAL...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Lamarca, Angela, Crona, Joakim, Ronot, Maxime, Opalinska, Marta, Lopez Lopez, Carlos, Pezzutti, Daniela, Najran, Pavan, Carvhalo, Luciana, Franca Bezerra, Regis Otaviano, Borg, Philip, Vietti Violi, Naik, Vidal Trueba, Hector, de Mestier, Louis, Schaefer, Niklaus, Sundin, Anders, Costa, Frederico, Pavel, Marianne, Dromain, Clarisse
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2019
Aiheet:
Gastrointestinal Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853102/
https://ncbi.nlm.nih.gov/pubmed/30910869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0672
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia